Trellus Health Management
Management criteria checks 1/4
Trellus Health's CEO is Marla Dubinsky, appointed in Jul 2022, has a tenure of 1.83 years. total yearly compensation is $146.54K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 5.42% of the company’s shares, worth £166.26K. The average tenure of the management team and the board of directors is 1.8 years and 2.5 years respectively.
Key information
Marla Dubinsky
Chief executive officer
US$146.5k
Total compensation
| CEO salary percentage | 100.0% |
| CEO tenure | 1.8yrs |
| CEO ownership | 5.4% |
| Management average tenure | 1.8yrs |
| Board average tenure | 2.5yrs |
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$6m |
| Sep 30 2023 | n/a | n/a | -US$7m |
| Jun 30 2023 | n/a | n/a | -US$8m |
| Mar 31 2023 | n/a | n/a | -US$8m |
| Dec 31 2022 | US$147k | US$147k | -US$9m |
| Sep 30 2022 | n/a | n/a | -US$9m |
| Jun 30 2022 | n/a | n/a | -US$9m |
| Mar 31 2022 | n/a | n/a | -US$8m |
| Dec 31 2021 | US$120k | n/a | -US$6m |
Compensation vs Market: Marla's total compensation ($USD146.54K) is below average for companies of similar size in the UK market ($USD347.32K).
Compensation vs Earnings: Marla's compensation has increased whilst the company is unprofitable.
CEO
Marla Dubinsky
1.8yrs
Tenure
US$146,542
Compensation
Dr. Marla Cindy Dubinsky, M.D. serves as Member of Scientific Advisory Board at Geneoscopy, Inc. since January 17, 2024. She serves as Chief, Division of Pediatric Gastroenterology at Mount Sinai Kravis Ch...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 1.8yrs | US$146.54k | 5.42% $ 166.3k | |
| Co-Founder & Chair of Scientific Advisory Board | no data | no data | 5.42% $ 166.4k | |
| Chief Financial Officer | less than a year | no data | no data | |
| Chief Operating Officer | 1.8yrs | no data | no data | |
| Chief Technology Officer | no data | no data | no data | |
| Director of Human Resources | no data | no data | no data | |
| Chief Medical Information Officer | 2.7yrs | no data | no data | |
| Head of Global Market Access - Travere Therapeutics & Member of Scientific Advisory Board | 2.3yrs | no data | no data | |
| Company Secretary | no data | no data | no data |
1.8yrs
Average Tenure
Experienced Management: TRLS's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 3.8yrs | US$146.54k | 5.42% $ 166.3k | |
| Co-Founder & Chair of Scientific Advisory Board | no data | no data | 5.42% $ 166.4k | |
| Head of Global Market Access - Travere Therapeutics & Member of Scientific Advisory Board | 1.9yrs | no data | no data | |
| Non-Executive Chairman | 3.2yrs | US$30.84k | 0.14% $ 4.3k | |
| Non-Executive Director | 1.9yrs | US$15.16k | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
2.5yrs
Average Tenure
Experienced Board: TRLS's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.